ILMN News

Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

Illumina To Webcast Upcoming Investor Conference

Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

Illumina Responds to Positive Updates from Chinese Ministry of Commerce

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025

Illumina advances personalized cancer care with new pharma development partnerships

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine